Sector
Expertise

Life
Sciences

Life Sciences

For nearly two decades, we’ve assisted pharmaceutical, biotechnology, consumer health, diagnostic, digital health, and medical device organisations in attracting and developing senior executives.

Whether you are a start-up, an established corporation, or a CMO, working on pre-clinical or clinical development, or commercialisation, we’ll help you build collaborative teams. We are skilled in customising our approach to attract diverse, globally-experienced leaders for science-driven environments.

Graphic

Key Trends in Life Sciences

1

Collaboration

New business models require collaborative approaches to pipeline innovation, manufacturing and supply, and a myriad of bench-to-bedside translations. This matrix of layered initiatives require leaders at all levels of the organisation to be capable of managing through influence, persuasion and compromise.

2

Precision and Personalised Medicine

The scientific advances that are giving rise to precision and personalised medicine are some of the great disruptors of our time. The radical changes that will emerge require leaders to be highly flexible, broad thinkers, who are comfortable challenging and ultimately dismantling the status quo.

3

Value-Driven Patient Access in a Limited Resource Healthcare Ecosystem

Long-term strategic planners who can realistically assess risk and make tough R&D decisions are needed to lead life science companies. They must provide value-driven access to a wide variety of customers and stakeholders in a healthcare ecosystem with limited resources, as well as develop innovative products and therapies. Alternative channels to market will be an inevitable component of any new strategy.

4

Diversity

Global patient demographics, emerging market demands and opportunities, and an increasingly female talent pool require inclusive leadership. Business leaders must become adept at recognising and prioritising the importance of diversity to harness its advantages for business and society.

5

Big Data, Digitalization, and Artificial Intelligence

Big data collection and usage; digitalization; and artificial intelligence in the entire life-cycle of therapies, from development to the point of patient access, are unstoppable trends. Wielding these technology tools in a meaningful way requires innovation leadership that is balanced by well-defined change management skills and a keen ability to prioritise.

Latest News in Life Sciences

September 13, 2019

One of the largest pharma companies in the world just got into cannabis

Life sciences

According to information procured exclusively ahead of a formal announcement Friday, a subsidiary of NYSE-traded giant Teva Pharmaceuticals has signed a deal with medical cannabis company Canndoc to distribute its […]

September 12, 2019

UK Government confirms disruption to medicines in event of no-deal Brexit

Life sciences

A document published by the UK Government laying out the worst case scenario if the UK leaves the European Union (EU) with no deal on 31st October stated there will […]

September 11, 2019

Changing of the guard at Swiss biotech Vifor; nabs Sanofi exec as new CMO

Life sciences

Vifor Pharma is losing a chief commercial officer but gaining a new chief medical officer in the form of Sanofi’s Klaus Henning Jensen. Jensen joins from the French Big Pharma […]

Subscribe to our Weekly Newsletter

Understanding your business is our business